Glioblastoma Clinical Trials in Glendale, AZ

Glioblastoma Clinical Trials in Glendale, AZ

View the best 10 glioblastoma medical studies in Glendale, Arizona. Access promising new therapies by applying to a Glendale-based Glioblastoma clinical trial.

Top rated glioblastoma clinical trials in Glendale, Arizona

Here are the top 8 medical studies for glioblastoma in Glendale, Arizona

Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of Children's Hospital of Alabama in Birmingham, United States.

Palbociclib

CDK4/6 Inhibitor

Recruiting1 awardPhase 2
This trial studies how well palbociclib works in treating pediatric patients with Rb positive solid tumors, non-Hodgkin lymphoma, or histiocytic disorders.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Temozolomide +2 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.
Image of Vidant Health in Greenville, United States.

GammaTile radiation therapy implantation +3 More

Brachytherapy

Recruiting3 awardsPhase 4
This trial will assess the feasibility and tolerability of addingGammaTile radiation therapy as an upfront boost at the time of maximum safe resection, along with the backbone of the current standard of care approach, concomitant and adjuvant temozolomide +/- TTF, for patients with newly diagnosed GBM.
Image of Mayo Clinic in Arizona in Scottsdale, United States.

WSD0922-FU

EGFR/EGFRvIII Inhibitor

Recruiting1 awardPhase 1
This trial is testing a targeted cancer treatment that blocks the EGFR protein. The trial will study the side effects of the treatment and what the best dose is. The treatment may help patients with brain and spinal cord cancers.
Image of Children's Hospital of Alabama in Birmingham, United States.

Olaparib

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is testing how well olaparib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with defects in DNA damage repair genes.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective for people with different types of cancer.
Image of Kaiser Permanente Los Angeles Medical Center in Los Angeles, United States.

Ramipril

ACE Inhibitor

Recruiting1 awardPhase 2
This trial is testing whether Ramipril can help cancer patients undergoing chemoradiation treatment by reducing memory loss. Patients will take the drug throughout treatment and for four months after. Memory will be assessed using neurocognitive tests.

Popular filter options for glioblastoma glendale trials

Clinical Trials With No Placebo

View 29 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.